 |
|
|
|
|
|
|
|
|
|
|
|
Call to Order and Opening Remarks |
|
|
| |
Diane Wara, M.D., Chair, NIH RAC |
|
|
| |
Webcast
|
|
| |
|
|
|
Minutes of the December 16, 2004, RAC Meeting |
|
|
| |
RAC Reviewers: Thomas Gelehrter, M.D. and Emmett Barkley, Ph.D. |
|
|
| |
Webcast
|
|
| |
|
|
|
|
Update on Human Gene Transfer Protocol #9906-322 |
|
|
| |
A Phase I Study of NGF Ex Vivo Gene Therapy for Alzheimer�s Disease |
|
|
| |
Mark H. Tuszynski, M.D., Ph.D., University of California, San Diego |
|
|
| |
Slides
Webcast
|
|
| |
|
|
|
|
Update on Human Gene Transfer Protocol # 0401-623 |
|
|
| |
A Phase I/II, Dose-Escalating, Randomized and Controlled Study to Assess the Safety, Tolerability, and Efficacy of CERE-110 (Adeno-Associated Virus [AAV]-Based, Vector-Mediated Delivery of Beta-Nerve Growth Factor [NGF]) in Subjects with Mild to Moderate Alzheimer�s Disease |
|
|
| |
Raymond T. Bartus, Ph.D., Ceregene, Inc. |
|
|
| |
Slides
Webcast
|
|
| |
|
|
|
|
Discussion of Human Gene Transfer Protocol #0501-689 |
|
|
| |
A Phase I, Open-Label Study of CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN]) to Assess the Safety and Tolerability of Intrastriatal Delivery to Subjects with Ideopathic Parkinson�s Disease |
|
|
| |
William J. Marks, Jr., M.D., University of California, San Francisco |
|
|
| |
Slides set 1
Slides set 2
Webcast
|
|
| |
|
|
|
|
Discussion of Human Gene Transfer Protocol #0501-691 |
|
|
| |
Phase I Trial of Systemic Administration of Edmonston Strain of Measle Virus, Genetically Engineered to Express NIS, with or without Cyclophosphamide, in Patients with Recurrent or Refractory Multiple Myeloma |
|
|
| |
Morie A. Gertz, M.D., Mayo Clinic, Rochester, MN
Angela Dispenzieri, M.D., Mayo Clinic, Rochester, MN |
|
|
| |
Slides
Webcast
|
|
| |
|
|
|
Presentation of American Association for the Advancement of Science Award to RAC Members |
|
|
| |
Elias A. Zerhouni, M.D., Director, National Institutes of Health |
|
|
| |
Webcast
|
|
| |
|
|
|
General Clinical Research Center Resources for Long-Term Followup |
|
|
| |
TBD |
|
|
| |
Slides
Webcast
|
|
| |
|
|
|
|
Discussion of Human Gene Transfer Protocol #0411-681 |
|
|
| |
Phase Ia/Ib Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer after Nonmyeloablative Conditioning |
|
|
| |
Richard Paul Junghans, M.D., Ph.D., School of Medicine, Boston University |
|
|
| |
Slides
Webcast
|
|
| |
|
|
|
|
Update and Discussion of Human Gene Transfer Protocol #0312-619 |
|
|
| |
Administration of a Replication-Deficient Adeno-Associated Virus Gene Transfer Vector Expressing the Human CLN2 cDNA to the Brain of Children with Late Infantile Neuronal Ceroid Lipofuscinosis |
|
|
| |
Ronald G. Crystal, M.D., Weill Medical College, Cornell University, New York, NY |
|
|
| |
Slides
Webcast
|
|
| |
|
|
|
ADJOURN |
|
| |
